| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |